Broadpoint.Gleacher Announces Launch of Healthcare Research Vertical

Broadpoint AmTech, Inc., a broker-dealer subsidiary of Broadpoint Gleacher Securities Group, Inc. (NASDAQ: BPSG), today announced the launch of its new Healthcare research vertical with the hiring of Amit Hazan and Joseph France.

Mr. Hazan joins the firm from Oppenheimer and Company where he covered medical device and diagnostics companies since 2006 in sectors including radiation therapy, diagnostics, women’s health, urology, orthopedics and other sub-sectors. He is widely recognized in the industry for his proactive research, detailed survey work, and strong relationships with investors and corporate managements alike. Mr. Hazan has a B.A. from UCLA and earned his JD/MBA from Santa Clara University. Also joining Mr. Hazan at Broadpoint AmTech are Jeremy Feffer and Brandon DeLeeuw, who worked with Mr. Hazan at Oppenheimer and are key contributors to the device team.

Mr. France joins the firm from Lenrock Management, a healthcare fund, to cover the facilities, managed care, and services companies. He has over twenty years of sell-side experience covering the industry, most recently at Bank of America and Credit Suisse. Mr. France has a wealth of industry experience and contacts and has been recognized by Institutional Investor 13 times in his career. He holds a B.S. in Pharmacy and an M.B.A. from the University of Kansas. Mr. France is a Chartered Financial Analyst.

Bob Meier, Chief Executive Officer of Broadpoint AmTech, said, “We strongly believe that the addition of the Healthcare vertical to our already strong Technology, Industrial, and soon to be REIT franchises will position us very well to continue to gain share at our key clients and drive revenue opportunities for the back half of 2010 and beyond.”

Eric Gleacher, Chief Executive Officer of Broadpoint.Gleacher, said, “Developing our equity platform is a critical element in our overall growth initiative and adding highly regarded research analysts like Amit and Joe is crucial to our success. We see exceptional opportunities in Healthcare and we are very pleased to welcome these accomplished individuals to our Research Department.”

About Broadpoint.Gleacher

Broadpoint Gleacher Securities Group, Inc. (NASDAQ: BPSG) is an independent investment bank that provides corporations and institutional investors with strategic, research-based investment opportunities, capital raising, and financial advisory services, including merger and acquisition, restructuring, recapitalization and strategic alternative analysis services. The Company offers a diverse range of products through the Debt Capital Markets, Investment Banking and Broadpoint DESCAP divisions of Broadpoint Capital, Inc., its Equity Capital Markets subsidiary, Broadpoint AmTech, and FA Technology Ventures Inc., its venture capital subsidiary. For more information, please visit www.bpsg.com.

Forward Looking Statements

This press release contains "forward-looking statements." These statements are not historical facts but instead represent the Company's belief regarding future events, many of which, by their nature, are inherently uncertain and outside of the Company's control. The Company's forward-looking statements are subject to various risks and uncertainties, including the conditions of the securities markets, generally, and acceptance of the Company's services within those markets and other risks and factors identified from time to time in the Company's filings with the Securities and Exchange Commission. It is possible that the Company's actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in its forward-looking statements. You are cautioned not to place undue reliance on these forward-looking statements. The Company does not undertake to update any of its forward-looking statements.